Rwanda Approves Growing Of Marijuana For Medical Purposes

By Nsunjo Erica
The government of Rwanda approved the cultivation, processing, and exportation of marijuana/cannabis for medicinal purposes.
“The government of Rwanda is considering the development of a medical cannabis industry in Rwanda, targeting medicinal and therapeutic products. With a focus on export markets and value addition. The government seeks to participate in the economic opportunities that this growing sector offers,” reads the statement.
Rwanda becomes the latest African country to legalize the growing of marijuana for medical purposes, and its government is targeting to grow its export earnings from the global cannabis market valued at $345 billion according to analysts New Frontier Data.
Rwanda’s Minister of Health Dr. Daniel Ngamije said that despite the government’s legalization with intentions of profiting from the production and export of marijuana, its use in the country is still prohibited.
“This will not give an excuse for drug abusers and dealers. The law against narcotics is available and it will continue to be enforced. Science has proved that this plant has elements that are often used to treat pain,” Dr. Ngamije said on state-run television Rwanda Broadcasting Agency on Tuesday.
Legalizing marijuana is a tough decision since it could be detrimental to the youth if tough control measures are not enforced to combat its illegal usage, however, Rwanda is targeting a boost in the country’s revenue.
The government of Rwanda says it is looking forward to reaping big from the economic opportunities it presents for medicinal purposes. The government also sees the marijuana industry as a strategic sector that will create jobs and businesses for communities.
What You Need To Know About Medical Marijuana
According to experts, medical marijuana involves the usage of the marijuana plant or chemicals in it to treat diseases or conditions. It’s basically the same product as recreational marijuana, but it’s taken for medical purposes.
According to the World Health Organization, marijuana is by far the most widely cultivated, trafficked, and abused illicit drug and accounts for half of all drug seizures worldwide.
Statistics about how many countries have legalized marijuana are not very clear but researchers say there are 4 countries in the world where both medical and recreational cannabis is 100% legal, and these include Canada, Georgia, South Africa, and Uruguay.
A number of other countries including African countries are tapping into the medical marijuana market, legalizing and relaxing laws on marijuana growing for medical purposes.
Experts say that marijuana is effective on illnesses such as cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological conditions, researchers are still looking more into more illnesses that can be cured by marijuana.
Some of the other countries that have allegedly legalized marijuana include Germany, Argentina, The United States, Australia, Israel, Chile, Italy, Poland, Czech Republic, Colombia, Belgium, Croatia, The Netherlands, Jamaica, Lesotho, and Zimbabwe among others.
About Soko Directory Team
Soko Directory is a Financial and Markets digital portal that tracks brands, listed firms on the NSE, SMEs and trend setters in the markets eco-system.Find us on Facebook: facebook.com/SokoDirectory and on Twitter: twitter.com/SokoDirectory
- January 2025 (119)
- February 2025 (191)
- March 2025 (212)
- April 2025 (193)
- May 2025 (161)
- June 2025 (157)
- July 2025 (226)
- August 2025 (211)
- September 2025 (270)
- October 2025 (149)
- January 2024 (238)
- February 2024 (227)
- March 2024 (190)
- April 2024 (133)
- May 2024 (157)
- June 2024 (145)
- July 2024 (136)
- August 2024 (154)
- September 2024 (212)
- October 2024 (255)
- November 2024 (196)
- December 2024 (143)
- January 2023 (182)
- February 2023 (203)
- March 2023 (322)
- April 2023 (297)
- May 2023 (267)
- June 2023 (214)
- July 2023 (212)
- August 2023 (257)
- September 2023 (237)
- October 2023 (264)
- November 2023 (286)
- December 2023 (177)
- January 2022 (293)
- February 2022 (329)
- March 2022 (358)
- April 2022 (292)
- May 2022 (271)
- June 2022 (232)
- July 2022 (278)
- August 2022 (253)
- September 2022 (246)
- October 2022 (196)
- November 2022 (232)
- December 2022 (167)
- January 2021 (182)
- February 2021 (227)
- March 2021 (325)
- April 2021 (259)
- May 2021 (285)
- June 2021 (272)
- July 2021 (277)
- August 2021 (232)
- September 2021 (271)
- October 2021 (304)
- November 2021 (364)
- December 2021 (249)
- January 2020 (272)
- February 2020 (310)
- March 2020 (390)
- April 2020 (321)
- May 2020 (335)
- June 2020 (327)
- July 2020 (333)
- August 2020 (276)
- September 2020 (214)
- October 2020 (233)
- November 2020 (242)
- December 2020 (187)
- January 2019 (251)
- February 2019 (215)
- March 2019 (283)
- April 2019 (254)
- May 2019 (269)
- June 2019 (249)
- July 2019 (335)
- August 2019 (293)
- September 2019 (306)
- October 2019 (313)
- November 2019 (362)
- December 2019 (318)
- January 2018 (291)
- February 2018 (213)
- March 2018 (275)
- April 2018 (223)
- May 2018 (235)
- June 2018 (176)
- July 2018 (256)
- August 2018 (247)
- September 2018 (255)
- October 2018 (282)
- November 2018 (282)
- December 2018 (184)
- January 2017 (183)
- February 2017 (194)
- March 2017 (207)
- April 2017 (104)
- May 2017 (169)
- June 2017 (205)
- July 2017 (189)
- August 2017 (195)
- September 2017 (186)
- October 2017 (235)
- November 2017 (253)
- December 2017 (266)
- January 2016 (164)
- February 2016 (165)
- March 2016 (189)
- April 2016 (143)
- May 2016 (245)
- June 2016 (182)
- July 2016 (271)
- August 2016 (247)
- September 2016 (233)
- October 2016 (191)
- November 2016 (243)
- December 2016 (153)
- January 2015 (1)
- February 2015 (4)
- March 2015 (164)
- April 2015 (107)
- May 2015 (116)
- June 2015 (119)
- July 2015 (145)
- August 2015 (157)
- September 2015 (186)
- October 2015 (169)
- November 2015 (173)
- December 2015 (205)
- March 2014 (2)
- March 2013 (10)
- June 2013 (1)
- March 2012 (7)
- April 2012 (15)
- May 2012 (1)
- July 2012 (1)
- August 2012 (4)
- October 2012 (2)
- November 2012 (2)
- December 2012 (1)